Claims for Patent: 6,114,608
✉ Email this page to a colleague
Summary for Patent: 6,114,608
Title: | Nucleic acid construct comprising bacillus thuringiensis cry1Ab gene |
Abstract: | The present invention is drawn to a novel DNA construct comprising an expression cassette having a constitutive promoter which functions in plant cells operably linked to a maize alcohol dehydrogenase intron, a DNA sequence of a gene encoding a Cry 1Ab protein, and a terminator functional in plants and optionally further comprising a second cassette including a promoter which functions in plants operably linked to a maize alcohol dehydrogenase intron, a DNA sequence of a gene encoding for phosphinothricin acetyl transferase, and a terminator functional in plants wherein the two cassettes are transcribed in the same direction. Also provided are transgenic plants, particularly maize plants, having such a construct stably incorporated into their genomes. |
Inventor(s): | Mettler; Irvin J (Richmond, CA), Dietrich; Paul S (Palo Alto, CA), Sinibaldi; Ralph M. (Fremont, CA) |
Assignee: | Novartis AG (Basel, CH) |
Application Number: | 09/042,426 |
Patent Claims: | 1. A nucleic acid construct comprising a first expression cassette comprising in operable linkage:
(i) a CaMV 35S promoter, wherein said promoter is the sequence described in SEQ ID NO: 1; (ii) a maize alcohol dehydrogenase intron, wherein said intron is the sequence described in SEQ ID NO: 2; (iii) a DNA molecule encoding an insecticidal Cry1Ab protein toxin, wherein said DNA molecule encoding an insecticidal Cry1Ab protein toxin is the sequence described in SEQ ID NO: 3; and (iv) a NOS terminator, wherein said terminator is the sequence described in SEQ ID NO: 4. 2. The nucleic acid construct according to claim 1, further comprising a second expression cassette comprising in operable linkage: (i) a CaMV 35S promoter, wherein said promoter is the sequence described in SEQ ID NO: 5; (ii) a maize alcohol dehydrogenase intron, wherein said intron is the sequence described in SEQ ID NO: 6; (iii) a DNA molecule encoding a phosphinothricin acetyl transferase, wherein said DNA molecule encoding a phosphinothricin acetyl transferase is the sequence described in SEQ ID NO: 7; and (iv) a NOS terminator, wherein said terminator is the sequence described in SEQ ID NO: 8. 3. The nucleic acid construct according to claim 2, wherein said first expression cassette and said second expression cassette are transcribed in the same direction. 4. A plant transformation vector comprising the nucleic acid construct according to claim 1. 5. The plant transformation vector according to claim 4, wherein said plant transformation vector is pZO1502, said pZO1502 having been deposited under ATCC Accession No: 209682. 6. A plant cell comprising the nucleic acid construct according to claim 1. 7. The plant cell according to claim 6, wherein said nucleic acid construct is stably integrated in the genome of said cell. 8. A plant comprising the nucleic acid construct according to claim 1. 9. The plant according to claim 8, wherein said nucleic acid construct is stably integrated in the genome of said plant. 10. The plant according to claim 8, wherein said plant is selected from the group consisting of maize, wheat, barley, sorghum and rice. 11. The plant according to claim 10, wherein said plant is a maize plant. 12. The plant according to claim 11, wherein said maize plant is field corn, sweet corn, white corn, silage corn or popcorn. 13. A seed of the plant according to claim 8. |
Details for Patent 6,114,608
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2017-03-14 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2017-03-14 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2017-03-14 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.